Investor Puts $130M Into Curaleaf's European Expansion
Cannabis giant Curaleaf announced Wednesday that it had secured $130 million from an unnamed institutional investor to help complete its previously announced purchase of European medical cannabis company EMMAC Life Sciences...To view the full article, register now.
Already a subscriber? Click here to view full article